Archive for the ‘research’ Category

Peer-Reviewed Paper: “The mRNA Vaccines Are Neither Safe Nor Effective, But Outright Dangerous:

https://stevekirsch.substack.com/p/now-published-in-the-peer-reviewed

Now published in the peer-reviewed scientific literature: “The mRNA vaccines are neither safe nor effective, but outright dangerous”

In case you missed it. Every health authority in the world should be warning the public about this. The paper was published Sept 21, 2022.

Steve Kirsch
Excerpts from Article
Figure 1. “Not safe or effective”
Executive summary

COVID-19 vaccines – An Australian Review was published in the peer-reviewed scientific literature on Sept 21, 2022.

Here’s the two sentences from the paper that everyone should read:

A worldwide Bayesian causal Impact analysis suggests that COVID-19 gene therapy (mRNA vaccine) causes more COVID-19 cases per million and more non-Covid deaths per million than are associated with COVID-19 [43].

An abundance of studies has shown that the mRNA vaccines are neither safe nor effective, but outright dangerous.

Excerpts from the conclusion
  1. Never in Vaccine history have 57 leading scientists and policy experts released a report questioning the safety and efficacy of a vaccine. They not only questioned the safety of the current Covid-19 injections, but were calling for an immediate end to all vaccination. Many doctors and scientists around the world have voiced similar misgivings and warned of consequences due to long-term side effects. Yet there is no discussion or even mention of studies that do not follow the narrative on safety and efficacy of Covid-19 vaccination.
  2. Medical experts that have questioned the safety of these vaccines have been attacked and demonized, called conspiracy theorists and have been threatened to be de-registered if they go against the narrative. Alternative treatments were prohibited and people who never practised medicine are telling experienced doctors how to do their job. AHPRA is doing the same here in Australia to the detriment and in ignorance of science.
The final paragraph sums it up

As scientists we put up hypotheses and test them using experiments. If a hypothesis is proven to be true according to current knowledge it might still change over time when new evidence comes to light. Hence, sharing and accumulating knowledge is the most important part of science. The question arises when and why this process of science has been changed. No discussion of new knowledge disputing the safety of the COVID-19 vaccines is allowed. Who gave bureaucrats the means to destroy the fundaments of science and tell scientists not to argue the science?

Every health authority in the world should inform the public about this study NOW

(See link for article)

_______________

For more:

Category:

research, vaccines, Viruses

UC San Francisco to Open Lyme Clinical Trials Center

https://www.bayarealyme.org/blog/national-lyme-clinical-trials-network-gains-its-first-west-coast-center-thanks-to-1m-donation-from-bay-area-lyme-foundation/

NATIONAL LYME CLINICAL TRIALS NETWORK GAINS ITS FIRST WEST COAST CENTER, THANKS TO $1M+ DONATION FROM BAY AREA LYME FOUNDATION

 | Diagnostics, News, TreatmentBy Bay Area Lyme Foundation

FOR IMMEDIATE RELEASE

National Lyme Clinical Trials Network Gains Its First West Coast Center, Thanks to $1M+ Donation from Bay Area Lyme Foundation

The University of California San Francisco Lyme Clinical Trials Center will support innovative clinical trials to develop treatments for patients with persistent Lyme disease

PORTOLA VALLEY, Calif., March 09, 2023 – Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces it has awarded more than $1M to the University of California San Francisco (UCSF) for the development of a Lyme Clinical Trials Center. This new center will become the first West Coast site of the Lyme Clinical Trials Network. The Network aims to address the need for high quality, innovative clinical trials to develop evidence-based treatments for patients with persistent Lyme symptoms following initial antibiotic treatment—a population that has grown to more than two million Americans and continues to increase.

“The founding of the UCSF Lyme Clinical Trials Center provides a unique opportunity for Lyme patients to participate in the next generation of therapeutic trials to combat this devastating disease,” said Charles Chiu, MD, PhD, of the University of California San Francisco who will lead the UCSF Lyme Clinical Trials Center. “Very few clinical trials have been initiated to investigate therapeutic solutions to address persistent symptoms of Lyme disease, and we hope to change this.”

UCSF will join the Lyme Clinical Trials Network led by Columbia University, which includes Children’s National Hospital (part of the National Institutes of Health), and Johns Hopkins University. This important effort is funded by the Steven & Alexandra Cohen Foundation.

“Bringing together these leading institutions from both coasts will enable collaboration that could accelerate the development of new treatments for patients with persistent Lyme disease, who currently have few options,” said Linda Giampa, executive director of the Bay Area Lyme Foundation. “Despite California having a great variety of tick-borne pathogens and having cases of Lyme as far back as the 1970s, patients who acquire these diseases in California have been underrepresented in research. We’re excited to have a unified network that can take into account the diversity of bacteria across geographies as these teams work together to tackle the lack of effective treatments for Lyme.”

Clinical symptoms may vary by region due to differences in tick-borne bacterial species and strains, making timely diagnosis and treatment extremely difficult. The creation of the UCSF Lyme Clinical Trials Center provides research and clinical scaffolding to help address these regional differences, with the hope of making treatment more effective, particularly for persistent disease.

“The Lyme Clinical Trials Network was created to help bring treatments and hope to Lyme disease patients and their families,” said Alexandra Cohen, president of the Steven & Alexandra Cohen Foundation. “We look forward to the continued growth of the Network and are excited to have UCSF join as the first West Coast site.”

Dr. Chiu will be overseeing the UCSF Lyme Clinical Trials Center, and its protocol development and grant writing. His team will be evaluating and treating patients for case registry and pilot studies, and publishing in conjunction with other Lyme Clinical Trials Network sites.

About Lyme disease
The most common vector-borne infectious disease in the US, Lyme disease is a potentially disabling infection caused by bacteria transmitted through the bite of an infected tick to people and pets, and/or potentially passed from a pregnant mother to her unborn baby. If caught early, most cases of Lyme disease can be effectively treated, but it is commonly misdiagnosed due to lack of awareness and inaccurate diagnostic tests. There are more than 500,000 new cases of Lyme disease each year, according to statistics released in 2018 by the CDC. As a result of the difficulty in diagnosing and treating Lyme disease, up to two million Americans may be suffering from the impact of its debilitating long-term symptoms and complications, according to Bay Area Lyme Foundation estimates.

About Bay Area Lyme Foundation
Bay Area Lyme Foundation, a national organization committed to making Lyme disease easy to diagnose and simple to cure, is the leading public not-for-profit sponsor of innovative Lyme disease research in the US. A 501c3 organization based in Silicon Valley, Bay Area Lyme Foundation collaborates with world-class scientists and institutions to accelerate medical breakthroughs for Lyme disease. It is also dedicated to providing reliable, fact-based information so that prevention and the importance of early treatment are common knowledge. A pivotal donation from The LaureL STEM FUND covers overhead costs and allows for 100% of all donor contributions to the Bay Area Lyme Foundation to go directly to research and prevention programs. For more information about Lyme disease or to get involved, visit www.bayarealyme.org or call us at 650-530-2439.

About the Steven & Alexandra Cohen Foundation
The Steven & Alexandra Cohen Foundation is committed to inspiring philanthropy and community service. They do this by creating awareness, offering guidance, and leading by example to show the world what giving can do. Their grants support public 501(c)3 nonprofit organizations based in the United States that either help people in need or solve complex problems. They also spearhead grassroots campaigns to encourage others to give.

# # #

Media contact:

Tara DiMilia

Phone: 908-369-7168

Tara.DiMilia@tmstrat.com

_________________

**Comment**

It remains to be seen just how “unified” this network of collaborators will be.  So far, I’ve not been impressed with what’s come out of Columbia (other than the recognition that Lyme/MSIDS can cause all sorts of cognitive and psychiatric issues), the NIH, or Johns Hopkins University, as ALL of them have utilized the faulty and misleading PTLDS moniker, which essentially ignores persistent infection.  A recent 2021 paper co-authored by 31 researchers from 19 separate institutions includes many of these researchers from these institutions listed in this collaboration, and while persistent infection is mentioned, the emphasis is always on three things: the acute phase, PTLDS, and a new Lyme vaccine.  The myopic focus is so predictable you could write the script personally.

Nobody wants to touch chronic Lyme with a ten foot pole.
What’s sad is what little progress has been made in over 40 years on a complex illness that is infecting people by the day.

Category:

Activism, Lyme, research

8X More People Died from Clot Shot Than of COVID & Spike Protein Found in Brain of Vaxxed Parkinson’s Patient

https://expose-news.com/2023/03/01/covid-vaccination-8x-deadlier-than-disease/

8x more people died due to C-19 Vaccination over 6 months than died of COVID-19 over 18 months according to UK GOV.

BY  ON 

Important excerpts:

When you consider that testing was compulsory in hospitals, despite it not being written in law, and they used the PCR test notorious for producing false positives, it’s not hard to see how the Government managed to mix tens of thousands of people who actually died of other causes into the Covid-19 death statistics.

But after months of trying to conceal the data, the Office for National Statistics published a report which contained figures on deaths by vaccination status.

But those figures may have actually been published by accident.

A report published by the ONS on September 13th 2021 misled the public into believing the majority of Covid-19 deaths were occurring among the unvaccinated population. But the date parameters used in their report – January 2nd 2021 to July 2nd 2021- include a huge swathe of deaths that were suffered during the second alleged wave of Covid-19 in January 2021, when barely anybody was vaccinated.

(See link for article and graphs)

_________________

http://

Link

DarkHorse Podcast Clip Feb. 28, 2023

V-Spike protein present in brain of dead Parkinson’s patient

https://www.mdpi.com/2076-393X/10/10/…

76-year-old man with Parkinson’s disease Died three weeks after third COVID-19 vaccination

Family of the deceased requested an autopsy, due to ambiguous clinical signs before death. PD was confirmed by post-mortem examinations.

  • Signs of aspiration pneumonia and systemic arteriosclerosis
  • Histopathological analyses of the brain Acute vasculitis (predominantly lymphocytic)
  • Multifocal necrotizing encephalitis
  • Pronounced inflammation Glial and lymphocytic reaction
  • In the heart Signs of chronic cardiomyopathy
  • Mild acute lympho-histiocytic myocarditis and vasculitis Patient had no history of COVID-19
  • Immunohistochemistry for SARS-CoV-2 antigens (spike and nucleocapsid proteins) was performed.
  • Only spike protein but no nucleocapsid protein could be detected, within the foci of inflammation, brain and heart
  • Spike protein detected in the endothelial cells of small blood vessels.
Quotes from the paper

Since no nucleocapsid protein could be detected, the presence of spike protein must be ascribed to vaccination rather than to viral infection. The findings corroborate previous reports of encephalitis and myocarditis caused by gene-based COVID-19 vaccines. A causal connection of these findings to the preceding COVID-19 vaccination was established by immunohistochemical demonstration of SARS-CoV-2 spike protein. The methodology introduced in this study should be useful for distinguishing between causation by COVID-19 vaccination or infection in ambiguous cases. Clinicians should take note of such case reports for the sake of early detection and management of such adverse events among their patients.

A thorough post-mortem examination of deaths in connection with COVID-19 vaccination should be considered in ambiguous circumstances, including histology.

For more:

Category:

Activism, research, vaccines, Viruses

CA Ticks Spread Lyme But That’s Not the Whole Story

https://www.globallymealliance.org/blog/california-ticks-can-spread-lyme-disease-but-thats-not-the-whole-story

California Ticks Can Spread Lyme Disease…But That’s Not the Whole Story

by Paul Killinger on February 24, 2023

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >California Ticks Can Spread Lyme Disease…But That’s Not the Whole Story</span>
If you find a tick bite from an Ixodes tick in California, it’s important to consider possible exposure to pathogens that cause more than Lyme disease

Originally published on Medzulabs.org 

The risk of contracting Lyme disease from a tick bite in California has been well-documented, though there is still a long way to go in educating health providers and the broader community in the exposure risk from a tick bite. TickReport’s surveillance of ticks from California (and Oregon and Washington) goes back as far as 2006 and has expanded in recent years.

What ticks are endemic (commonly and consistently found in wild populations) to California and other West Coast states?

That’s a big question, and there are a few dozen species from different genera or families. Many of those species are specialist feeders and—if everything goes “right” in their life cycle—they will only feed on certain wild mammals, birds, or lizards and will bite humans very rarely. That’s doesn’t mean that finding one of these “specialists” attached to ourselves or a family member is impossible: it’s just much less common (and a topic we’ll try to visit soon in another post).

Our surveillance shows that the majority (91.5%) of human or human-adjacent (dogs, cats, horses, etc) tick bites are caused by the following ticks:

  • Ixodes pacificus (“Western black-legged tick,” a close relative of the Deer tick in the Eastern U.S.)
  • Dermacentor variabilis (“American dog tick”)
  • Dermacentor occidentalis (“Pacific Coast tick”)
  • Dermacentor andersoni (“Rocky Mountain Wood tick”)
  • Ixodes spinipalpis
  • Ixodes angustus
What pathogens can these ticks transmit to humans?

Vector competence (the ability of a vector like a tick to transmit a given disease-causing pathogen) tends to run along genus lines, so species within the Ixodes genus tend to be able to transmit pathogens X and Y but not Z, while Dermacentor species tend to transmit Z but not X and Y.

The most common pathogen found in California ticks is Borrelia burgdorferi, which causes Lyme disease in humans and pets. But there’s more than Lyme in those hills! If you find a tick bite from an Ixodes tick in California, it’s also important to consider possible exposure to these pathogens:

  • Borrelia miyamotoi: a bacterium that can cause hard tick relapsing fever—sometimes called Borrelia miyamotoi disease.
  • Anaplasma phagocytophilum: a bacterium that can cause Human granulocyctic Anaplasmosis.
*For every two ticks we find infected with Borrelia burgdorferi (Lyme disease bacteria), we detect one (or more) of these other pathogens

It’s vital that both tick surveillance and diagnostic approaches keep these non-Lyme pathogens in mind. For every two ticks we find infected with Borrelia burgdorferi (Lyme disease bacteria), we detect one (or more) of these other pathogens, so be sure to resist Lyme Tunnel Vision when responding to a tick bite! Common diagnostic tests for Lyme disease have a specific focus on Lyme disease and will not detect infection by these other pathogens if present. Make sure you and your doctor are considering the whole story of a tick bite.

To learn more about the pathogens we find in West Coast ticks, browse our real-time testing data at TickReport.com/stats. If you find and remove a tick, arrange for fast and accurate identification and testing at TickReport.com.
The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history. 

Paul Killinger oversees tick surveillance and pathogen testing at the TickReport testing lab in Amherst, Massachusetts. He has led the lab's public health education and outreach since 2018.

Category:

Activism, Anaplasmosis, Borrelia Miyamotoi (Relapsing Fever Group), Lyme, research, Testing, Ticks, Transmission

Reversible Dementia Caused By Lyme: Case Study

https://www.globallymealliance.org/news/2023-case-study-reversible-dementia-caused-by-lyme-disease

2023 Case Study: Reversible Dementia Caused by Lyme Disease

by Admin at Global Lyme Alliance on February 27, 2023

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >2023 Case Study: Reversible Dementia Caused by Lyme Disease</span>
A case of reversible dementia with Lyme treatment?

Annals of Geriatric Medicine and Research (Sanchini, C., et al.) 2.6.23, published “A case of reversible dementia? Dementia vs delirium in Lyme disease.” The report describes a case of a 75-year-old man who was admitted to the Alzheimer’s Disease Care Unit of the Institute Golgi in Abbiategrasso, Italy.

According to the case report, the man had been recently discharged from a local hospital with a diagnosis of “cognitive impairment, deficit of memory, and poor capacity of criticism compatible with degenerative disease.”

The patient was a multilingual interpreter with a high school degree. He enjoyed walking in the countryside with his dog, but he had been experiencing knee pain – for about a month. The pain would worsen and migrate to his other joints. The case also reports that he had been showing minor memory deficiency and ideomotor slowdown.

A CT scan showed abnormalities, but blood tests were within normal ranges, the only thing noted was increased inflammation. As time went on, the patient became more confused and disoriented, presenting with hallucinations, aggressive behavior, and insomnia.

With the patient having arthritis, he was tested for Lyme. Lyme antibodies were detected by the western blot. Initial intravenous ceftriaxone treatments did not alleviate the patient’s symptoms. Oral doxycycline was administered as well as a brief course of quetiapine to manage the hallucinations.

Soon after 6–7 days of antibiotic therapy, delusional symptoms and hallucinations were reduced, and his insomnia improved. Urinary incontinence completely resolved. His behavioral profile also improved, with a reduction in agitation, aggression, and depression. His language became more fluent and communicative.

Read the full case study here.

_______________

**Comment**

This proves that antimicrobial therapy helps Lyme/MSIDS patients, unfortunately, this patient will most probably suffer relapses as this duration of therapy has been proven to be insufficient time and time again.  Herein lies one of the most glaring problems that has not changed in 40 years.  The other glaring problem is the coinfection involvement that often occurs, necessitating different medications.

But, the band plays on…..

For more:

How many more dementia/Alzheimer’s patients have undiagnosed tick-borne illness?

Category:

Alzheimer's, Lyme, research, Treatment